• 1. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
• 2. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 3. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 4. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
• 5. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidinecarboxylic acids
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidinecarboxylic acids and derivatives Piperidinecarboxylic acids

Ethyl 3-methylpiperidine-3-carboxylate (CAS No. 170843-43-3): A Comprehensive Overview in Modern Chemical Research

Ethyl 3-methylpiperidine-3-carboxylate (CAS No. 170843-43-3) is a significant compound in the realm of chemical biology and pharmaceutical research. This compound, characterized by its unique structural and functional properties, has garnered considerable attention due to its potential applications in drug development and synthetic chemistry. The piperidine ring, a key structural motif, contributes to the molecule's versatility, making it a valuable intermediate in the synthesis of more complex organic molecules.

The compound's molecular structure, featuring a carboxylate ester group and a methyl-substituted piperidine ring, positions it as a versatile building block for medicinal chemists. The ester functionality not only influences the compound's solubility and reactivity but also opens up possibilities for further derivatization, enabling the creation of novel derivatives with tailored biological activities. This adaptability has made Ethyl 3-methylpiperidine-3-carboxylate a subject of interest in various research avenues.

In recent years, the pharmaceutical industry has seen a surge in the exploration of piperidine derivatives due to their favorable pharmacokinetic properties and potential therapeutic benefits. Ethyl 3-methylpiperidine-3-carboxylate, with its well-defined structure, has been investigated for its role in developing new drugs targeting neurological disorders, cardiovascular diseases, and infectious diseases. Its ability to serve as a precursor for more complex molecules has been particularly valuable in these endeavors.

One of the most compelling aspects of Ethyl 3-methylpiperidine-3-carboxylate is its utility in the synthesis of bioactive molecules. The presence of both the carboxylate ester and the methyl-substituted piperidine ring allows for diverse chemical modifications, enabling researchers to fine-tune the compound's properties for specific applications. This flexibility has been exploited in several studies aimed at developing novel therapeutic agents.

Recent advancements in computational chemistry have further highlighted the importance of Ethyl 3-methylpiperidine-3-carboxylate in drug discovery. Molecular modeling studies have demonstrated its potential as a scaffold for small-molecule drugs, providing insights into how it can interact with biological targets. These studies have not only enhanced our understanding of the compound's mechanism of action but also paved the way for more efficient drug design strategies.

The synthesis of Ethyl 3-methylpiperidine-3-carboxylate involves multi-step organic reactions that showcase the compound's synthetic utility. The process typically begins with the preparation of 3-methylpiperidine-3-carboxylic acid, which is then esterified to yield the ethyl derivative. This synthetic route highlights the compound's role as an intermediate in organic synthesis and underscores its importance in pharmaceutical manufacturing.

From a biological perspective, Ethyl 3-methylpiperidine-3-carboxylate has shown promise in preclinical studies as a potential therapeutic agent. Its structural features suggest interactions with various biological targets, making it a candidate for further investigation in drug development pipelines. The compound's ability to modulate biological pathways has been explored in models of neurological disorders, where it has demonstrated potential benefits.

The growing interest in Ethyl 3-methylpiperidine-3-carboxylate is also reflected in its increasing presence in scientific literature. Researchers worldwide are investigating its applications across different fields, from medicinal chemistry to materials science. This widespread interest underscores the compound's significance and highlights its potential to contribute to advancements in multiple domains.

In conclusion, Ethyl 3-methylpiperidine-3-carboxylate (CAS No. 170843-43-3) is a multifaceted compound with significant implications in chemical biology and pharmaceutical research. Its unique structural features and versatile reactivity make it a valuable tool for drug development and synthetic chemistry. As research continues to uncover new applications for this compound, its importance is likely to grow even further, solidifying its place as a key player in modern chemical research.

• 57487-93-1(Ethyl 1-ethylpiperidine-3-carboxylate)
• 278789-72-3(Ethyl (3s)-3-methylpiperidine-3-carboxylate)
• 297172-22-6(2-Oxa-7-azaspiro[4.5]decan-1-one)
• 5166-67-6(Ethyl 1-Methylpiperidine-3-carboxylate)
• 10558-62-0(3-Piperidinecarboxylicacid, 1-methyl-, butyl ester)
• 128200-19-1(ethyl 1-(3-ethoxy-3-oxopropyl)piperidine-3-carboxylate)
• 205194-12-3(3-Piperidinecarboxylicacid, 1-methyl-, ethyl ester, (3R)-)
• 100050-04-2(3-Piperidinecarboxylic acid, 1-propyl-, ethyl ester)
• 297172-01-1(ethyl (3R)-3-methylpiperidine-3-carboxylate)
• 176523-95-8(Ethyl 3-methylpiperidine-3-carboxylate hydrochloride)